Candida glabrata Prosthetic Joint Infection Managed with Ibrexafungerp

We report a case of a triazole and echinocandin-resistant <i>C. glabrata</i> right shoulder prosthetic joint infection in a 60-year-old woman. The patient underwent surgery and received the novel triterpenoid antifungal agent ibrexafungerp. She initially improved, but relapsed four months post-treatment. This case highlights the potential role of ibrexafungerp in multidrug-resistant <i>Candida</i> infections.